Wachtell, Lipton, Rosen & Katz has guided Perrigo Co. plc in connection with the sale of its HRA Pharma Rare Diseases business unit to pharmaceutical company Esteve Healthcare SL for 275 million euros ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback